These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17456201)

  • 21. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.
    Brooks AM; Carter V; Liew A; Marshall H; Aldibbiat A; Sheerin NS; Manas DM; White SA; Shaw JA
    Am J Transplant; 2015 Dec; 15(12):3239-46. PubMed ID: 26227015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat pancreatic islet pretreatment with anti-MHC class II monoclonal antibodies and culture: in vitro MLIC test response does not predict islet allograft survival.
    Bretzel RG; Flesch BK; Brennenstuhl G; Greiner I; Hering BJ; Woehrle M; Federlin K
    Acta Diabetol; 1993; 30(1):49-56. PubMed ID: 8329731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk of sensitization after failed islet transplantation.
    Campbell PM; Senior PA; Salam A; Labranche K; Bigam DL; Kneteman NM; Imes S; Halpin A; Ryan EA; Shapiro AM
    Am J Transplant; 2007 Oct; 7(10):2311-7. PubMed ID: 17845564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
    Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
    Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
    Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
    Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
    Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of xenograft rejection by masking donor HLA class I antigens.
    Faustman D; Coe C
    Science; 1991 Jun; 252(5013):1700-2. PubMed ID: 1710828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients.
    van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO
    Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.
    Piemonti L; Everly MJ; Maffi P; Scavini M; Poli F; Nano R; Cardillo M; Melzi R; Mercalli A; Sordi V; Lampasona V; Espadas de Arias A; Scalamogna M; Bosi E; Bonifacio E; Secchi A; Terasaki PI
    Diabetes; 2013 May; 62(5):1656-64. PubMed ID: 23274902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.
    van der Mast BJ; van Besouw NM; Witvliet MD; de Kuiper P; Smak Gregoor P; van Gelder T; Weimar W; Claas FH
    Transplantation; 2003 Mar; 75(6):871-7. PubMed ID: 12660517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.